Literature DB >> 20211338

Prevalence and clinical characteristics of nondilated cardiomyopathy and the effect of atrial fibrillation.

Alexander Doumas1, Timothy S Draper, Edgar C Schick, William H Gaasch.   

Abstract

The treatment of patients with chronic heart failure and those with asymptomatic left ventricular (LV) dysfunction has focused primarily on patients with LV enlargement and a low ejection fraction (EF). Little attention has been paid to those with a normal chamber size and a low EF. We sought to examine the LV geometry and clinical characteristics in such patients with nondilated cardiomyopathy. Of 3,350 transthoracic echocardiograms performed during a 6-month period, 696 showed an EF of < or =0.45. The patients with an end-diastolic diameter of >56 mm, regional wall motion abnormalities, or valvular disease were excluded. Of the 696 patients, 98 met these criteria, and their medical records were reviewed. The average age was 71 +/- 14 years, and 56% were men. Common co-morbidities included hypertension in 52% and atrial fibrillation (AF) in 43%. Only 22% had disabling cardiac symptoms (functional class III or greater). The average end-diastolic dimension was 49 +/- 5 mm, and the EF was 34 +/- 8%. LV hypertrophic remodeling was present in 53%. A second echocardiogram (422 +/- 177 days after the baseline study) was available for 54 patients. The chamber size was unchanged, but the EF had increased from 33 +/- 8% to 40 +/- 14% (p <0.01). The improvement in EF was seen in the group with AF (33 +/- 6% to 44 +/- 15%, p <0.01) but not in those with normal sinus rhythm (33 +/- 9% to 37 +/- 12%, p = NS). In conclusion, 14% of patients with an EF of < or =0.45 had nondilated cardiomyopathy, often with LV hypertrophic remodeling and/or AF. An improvement in LV function can be expected in many patients with nondilated cardiomyopathy, particularly those with AF. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20211338     DOI: 10.1016/j.amjcard.2009.10.068

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity.

Authors:  Mahmoud Abdellatif; Viktoria Trummer-Herbst; Alexander Martin Heberle; Alina Humnig; Tobias Pendl; Sylvère Durand; Giulia Cerrato; Sebastian J Hofer; Moydul Islam; Julia Voglhuber; José Miguel Ramos Pittol; Oliver Kepp; Gerald Hoefler; Albrecht Schmidt; Peter P Rainer; Daniel Scherr; Dirk von Lewinski; Egbert Bisping; Julie R McMullen; Abhinav Diwan; Tobias Eisenberg; Frank Madeo; Kathrin Thedieck; Guido Kroemer; Simon Sedej
Journal:  Circulation       Date:  2022-05-26       Impact factor: 39.918

2.  Ventricular diastolic dimension over maximal myocardial thickness is robust landmark of systolic impairment in patients with hypertrophic cardiomyopathy.

Authors:  Marko Boban; Vladimir Pesa; Helena Antic Kauzlaric; Sandro Brusich; Ante Rotim; Tomislav Madzar; Marinko Zulj; Aleksandar Vcev
Journal:  Med Sci Monit       Date:  2018-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.